CNTA   $17.05  -6.27% Market Closed After Close 17.98 5.45%

Centessa Pharmaceuticals PLC
Total Cash 294.83M
totalCashPerShare 2.602
EBITDA -155.10M
Total Debt 85.65M
quickRatio 12.776
currentRatio 13.287
Total Revenue 6.85M
debtToEquity 29.846
Revenue/Share 0.068
ROA -0.24543
ROE -0.55839
grossProfits
freeCashflow -91.92M
operatingCashflow -146.31M
earningsGrowth
revenueGrowth
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -22.684519
profitMargins 0.0
enterpriseValue 1.60B
forwardPE -9.350877
floatShares 76.54M
sharesOutstanding 128.57M
sharesShort 2.01M
sharesShortPriorMonth 1.50M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.79%
Short Ratio help_outline 3.66%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 2.536
Price To Book help_outline 6.31
earningsQuarterlyGrowth
netIncomeToCommon -157.35M
trailingEps -1.55%
forwardEps -1.71%
enterpriseToEbitda -10.33
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.42 3Q 2024
institutionsCount 106
lastUpdated Nov. 7, 2024, 5:04 a.m.